section name header

Y-Site Injection Compatibility (1:1 Mixture)

Ibuprofen lysinate

(Mfr: OVA)(Conc: 10 mg/mL)

QMark

Fat emulsion, intravenous

(Mfr: BA)(Conc: 10%)

Remarks:

Could not be evaluated because of initial milky white opaque appearance and high turbidity

Ref:

3541